Pegaspargase (Intramuscular Route, Intravenous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Pegaspargase (Intramuscular Route, Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Oncaspar

Description

Pegaspargase belongs to the general group of medicines known as antineoplastics. It is used with other cancer medicines as a first-line treatment to a certain type of blood cancer called acute lymphoblastic leukemia (ALL). This medicine also treats ALL in patients who have had serious allergic reactions to L-asparaginase .

Pegaspargase seems to interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells also may be affected by pegaspargase, other effects also occur. Some of these effects may be serious and must be reported to your doctor.

Before you begin treatment with pegaspargase, you and your doctor should talk about the good this medicine will do as well as the risks of using it.

Pegaspargase is to be administered only by or under the immediate supervision of your doctor.

This medicine is available only with your doctor's prescription .

Before Using
DR601733 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger